Astragalus membranaceus (AM) and Panax ginseng (PG) are two herbal products with a long history of clinical usage in traditional Chinese medicine (TCM), used in treating a variety of diseases especially in stimulating or inhibiting the immune system. To elucidate the immunity effect of these two traditional Chinese medicine on animal model, four pharmacodynamic indexes (spleen index, thymus index, splenic lymphocyte proliferation and cytotoxic activity of natural killer (NK) cells) were observed on mice. Furthermore, metabolic profiles of plasma were also analyzed by ultraperformance liquid chromatography quadrupole-time-of-flight mass spectrometry (UPLC-Q/TOF-MS, LC-MS) method. All mice were intragastric administrated at three doses (low dose, moderate dose and high dose) once daily for 30 days. Principal components analysis (PCA) and orthogonal projection to latent structure discriminant analysis (OPLS-DA) were performed on LC-MS spectra of plasma, showing that all administration groups developed the disturbance of internal milieu, compared to the blank control (BC) group. Besides, correlation analysis was conducted between pharmacodynamic index and metabolic index. It indicated that uracil, lysoPC(18:3(6Z,9Z,12Z)), sphinganine, LPA(0:0/16:0), UDP-glucuronate, PC(14:0/18:0) were five main endogenous substances, much closely related to four immunological indexes. Glycerophospholipid metabolism was found in both AM and PG groups. Pyrimidine metabolism and sphingolipid metabolism were closely regulated in AM groups. Energy metabolism (starch and sucrose metabolism, Pentose and glucuronate interconversions, together with glycerolipid metabolism) and glycerolipid metabolism were found in PG groups. These findings could contribute to the understanding of mice plasmatic metabolic profiling after long-term administration. Comparative immune-related metabolomic analysis of AM and PG was obtained on the base of pathway analysis of immune-related biomarkers. PG groups trended to have effect on cytotoxic activity of NK cells. AM groups trended to effect thymus index. Our work provides a detailed interpretation of immunological characteristics in different traditional Chinese medicine on metabonomic level. [17, 18] . Both AM and PG could improve fatigue, promote recovery of body and enhance immunity. During thousands of years of clinical practice of TCM, people trend to use these two drugs for tonifying Qi.
Introduction

Animal experiment and sample collection
Eighty-four Institute of Cancer Research (ICR) mice (20 g ± 0.02 g), half male and half female, were randomly divided into BC group , low-dose AM group (LAM, 5 g/kg), moderate-dose AM group (MAM, 25 g/kg), high-dose AM group (HAM, 50 g/kg), low-dose PG group (LPG, 1.5 g/kg), moderate-dose PG group (MPG, 7.5 g/kg) and high-dose PG group (HPG, 15 g/kg). Before drug administration, the mice were acclimatized for 7 days in a rearing environment with 12 h light-dark cycle (light on from 6:00 to 18:00 h) at ambient temperature (22-24°C) with 60% relative humidity. Mice were fasted for 12 h with free access to water. They were fed continuously for 30 days by intragastric administration of AM or PG. After administration, serial blood samples (about 1.00 mL) were collected by eyeballs extraction into heparin-containing tubes and centrifuged at 3000 rpm for 15 min. Plasma was separated and stored at -20 °C until analysis. Furthermore, another two studies were performed, which were splenic lymphocyte proliferation assay and cytotoxic activity of natural killer (NK) cells assay. All experimental procedures were approved by the Institutional Animal Care Committee of Chinese Academy of Medical Sciences.
Splenic lymphocyte proliferation assay
Mouse spleen was removed, grinded and passed through a stainless mesh (200Φ) by aseptic operation. The final concentration of spleen suspension cells (SSCs) was adjusted to 3×10 6 /mL by RPMI1640 medium containing 10% NBS (ratios of living cells was 96%-98% by trypan blue exclusion).
Spleen suspension cells (1 mL per well) proliferation were stimulated by Con A (final concentration 3.0 μg/mL) in 24 well cell culture cluster and then cultured at 37 °C in 5% CO2 cultivating box for 68 h. After 68 h incubation and then centrifuged at 1000 rpm/min for 10min. The supernatant was discarded and the same volume of RMPI 1640 medium without 10% NBS was added into each well. Subsequently, MTT solution (5mg/mL) was added into the wells with a volume of 100 μL per well, and intermixed into uniformity softly, put it into 5% CO2 cultivating box again. After another 4 h incubation and then centrifuged at 4200 rpm for 10 min. 500 μL supernatant was discarded and 800 μL dimethyl surtoxide (DMSO) was added into each well. The absorbance was measured at 570 nm by Enzyme Mark Instrument, and the average optical density (OD) value was calculated. The stimulation index (SI) was calculated according to the following formula: SI = OD Con A stimulated lymphocyte proliferation -OD spontaneous lymphocyte proliferation without Con A. SI was used to assess the difference of proliferation ability between treatment groups and BC group.
Cytotoxic activity of natural killer cells assay
Yac-1 cells were used as target cells and washed by hank's solution three times in pre-experiment. Finally, the concentration of target cells was adjusted to 4×10 5 /mL by RPMI1640 medium containing 10% NBS (ratios of living cells was 98% by trypan blue exclusion).
SCCs were collected by the same method in splenic lymphocyte proliferation assay. After speed centrifugation at 1000 rpm/min for 10 min, 500 μL sterile water was added to splitting erythrocyte for 20 seconds and then 8.0 mL hank's solution was added. Finally, the concentration of cells was adjusted to 2×10 7 /mL by RPMI1640 medium containing 10% NBS (ratios of living cells was 97% by trypan blue exclusion).
SCCs without erythrocyte were regarded as effector cells. Equivalent amount (100 μL) of RPMI1640 medium, 1% NP40 solution and effector cells were added into the wells with 100 μL target cells in 96 well cell culture cluster, respectively. At 50:1 effector-target ratio, the lytic activity of NK cell was investigated. Three independent experiments ran in duplicate. After 4 hours incubation in 5% CO2 cultivating box, centrifuged at 1500 rpm/min for 10 min and 100 μL lactic dehydrogenase solution (LDH) was added to the supernatant. LDH contained lithium lactate (5×10 
Viscera index analysis
Spleen and thymus of mice were stripped under sterile environment, weighted and calculated after the last administration. Spleen index was calculated by spleen weight (mg) divided / weight (g). Thymus index was calculated by thymus weight (mg) / body weight (g).
Sample preparation for metabolite profiling
Plasma samples were thawed at room temperature and 100 μL of plasma sample was transferred into an eppendorf tube, and then 300 μL of ice-cold acetonitrile was added to precipitate the plasma proteins. Samples were then vortexed for 1 min and stored in refrigerated (4°C) condition for 3 hours. After that, centrifuged at 16,000 rpm for 15 min (4°C) and the supernatant was transferred and evaporated to dryness under a vacuum centrifugal concentrator. The residue was reconstituted in 200 µL of 15% acetonitrile-water, and a 1 µL aliquot was injected for analysis.
Validation of the metabonomic method
Reproducibility and precision of method were investigated. Relative standard deviation (RSD) of detected retention time, mass-to-charge ratio (m/z), peak height and peak intensity were investigated. Typical pooled samples were used as analysis object for quality control (QC). 72 pooled plasma samples were mixed together of equal volumes (10 μL) and prepared as Sample Preparation method.
LC-MS and LC-MS/MS platforms for metabolite profiling
UPLC analysis was conducted on a 1290 UPLC system (Agilent Technologies, Santa Clara, CA, USA). Injection volume was 1.0 μL and the flow rate of the mobile phase was 0.40 mL/min. Separation of analytes was performed on a reversed phase Agilent Zorbax XDB-C18 column (2.1 mm × 50 mm, particle size 3.5 µm) with the column oven set to 35 •C. The elution gradient was eluted from the column under a gradient of 0.1% v/v formic acid in water (A) and acetonitrile (B) and optimized separation was obtained according to a linear gradient (0-1.5 min, 5% B; 1.5-3 min, 5-50% B; 3-16 min, 50-95% B; 16-21 min, 95% B, returned to 5% B for 5 min). Acetonitrile as a blank solution was run every four samples. The reference nebulizer was set at 1 psi. The MS/MS spectra of potential biomarkers were obtained by UPLC-MS/MS method in target mass mode. Ultra-performance liquid chromatography method was the same as this in LC-MS method. Collision energy were set at 10, 20 and 40 eV, respectively.
Data Processing
The collected raw data were extracted and analyzed by the function of Molecular Feature Extractor (MFE) within MassHunter Qualitative Analysis (Agilent Technologies). The retention time, m/z value, and the volume for each compound were investigated. The data were converted into the .cef format by Agilent MassHunter Profinder (AMP, Agilent Technologies) for targeted recursive feature finding, for peak detection and alignment. And then, .cef data were imported into Mass Profiler Professional (MPP, Agilent Technologies) for differential analysis. To compare the metabolite profiles among BC, AM and PG groups, the Student's t-test and analysis of variance were conducted. Compounds with the value of p < 0.05 and fold change ≥2.0 were selected as preliminary potential biomarkers. Then, the biomarker formulations were generated and queried using the Agilent METLIN Compound Database (assistant software package in MPP).
PCA and OPLS-DA models were performed by SIMCA-P 14.1 (Umetrics, Umea, Sweden). Variable importance in the projection (VIP) values was taken as key point for peak selection. Student's t test was used to measure the significance of each metabolite. Metabolites of VIP value larger than 1.0 (VIP>1.0, p<0.05) was considered as characteristic metabolites. The typical fragmentation patterns of selected biomarkers were analyzed based on the MS/MS data information.
Besides, the metabolic pathway analysis of proposed biomarkers was analyzed by MetaboAnalyst3.0 with KEGG (http://www.genome.jp/kegg/) and the Human Metabolome Database (http://www.hmdb.ca/). Based on the obtained pathway information, a cross-over analysis of identified biomarkers was analyzed comprehensively, using related references.
Correlation analysis was conducted by using SPSS 24.0 for Windows (IBM, Armonk, NY, USA). Pearson's correlation coefficient was used to investigate correlations between the four pharmacodynamics indexes and identified biomarkers, to find out immune-related biomarkers.
Results and discussion 3.1 Method validation
A rigorous data and complete analysis of experiment are in close with the application of optimized method. So, it is necessary to do an evaluation of analysis method in pre-experiment to assure repeatability and precision of plasma sample analysis. To investigate the reproducibility of untargeted analyses of plasma, we performed 40 repeat analyses on a 1.0 μL injected volume of a single QC sample and analyzed the acquired data. Ten ions in positive and tent ions in negative mode were chosen as targeted ions. The RSD value was calculated as a measurement of method repeatability. Besides, intra-and inter-day biological variations were used to determine the precision of the proposed method. Twelve replicates of the QC samples were analyzed within one day and inter-day variability test was conducted in consecutive 3 days. Variations were represented by RSD. These were shown in Table 1 . 
Pharmacodynamics evaluation of immune index in mice 3.2.1 Effect of AM and PG on mice weight and viscera index
There was no significant difference in the body weights of mice between treatment groups and BC group in Figure 1A . Besides, no significant difference was also found in thymus index in Figure  1B . The index numbers of spleen of MPG, HPG, LAM and MAM groups were significantly higher than BC group (p<0.05) in Figure 1C . It showed that long-term administration of AM or PG contributed to strengthen the spleen index of mice, compared to the BC group.
Effect of AM and PG on the proliferation of splenic lymphocytes
The SI in treatment groups with AM and PG all showed a significant increase as compared with that in BC group in Figure 1D . It indicated that AM and PG improved adaptive immunity in mediating proliferation of splenic lymphocytes.
Effect of AM and PG on the cytotoxic activity of NK cells
Compared to BC group, the spontaneous lymphocyte-mediated cytotoxicity of spleen against YAC-1 target cells were increased by 71.74% in LPG (p<0.01) and increased by 48.67% in LAM groups in Figure 1E . It indicated that AM and PG improved innate immunity in mediating cytotoxic activity of NK cells. The behavior of immune system function is a comprehensive reflection of immune organs and cells in vivo. Once physiological equilibrium is broken by internal or external factors, numerous functional and phenotypic changes in monocytes, macrophages, T and B-lymphocyte cells may happened.
In general, spleen and thymus are two important immune organs in vivo. Spleen is the biggest immune organ with a plenty of lymphocytes and macrophages, which accounting for 25 percent of weight in total lymphatic tissues. As a central immune organ, spleen is responsible for both humoral and cellular immunity. Thymus is a place that lymphocytes differentiate, grow and mature. The results indicated that AM or PG may improve immune activities by increasing spleen index rather than thymus index. Spleen is used a reservoir of blood and clears aged erythrocytes to improve the blood circulation. In this way, blood may play an important role in regulating immune system.
During the early phases of infections, innate immune response is triggered prior to adaptive immune response. NK cells are quickly gained from blood circulation and fight with target cells such as tumor cells [25] , virus-infected cells [26] and parasite [27] . In this way, down-stream adaptive immune response is strengthened [28] . From the data of NK cell activity assay, the NK cell activity increased in both AM and PG groups with significant difference. In splenocyte proliferation assay, splenocyte proliferation also increased. Long-term administration of AM and PG had a demonstrable positive effect on innate and adaptive immune. Our work was in compliance with previous studies, which AM and PG could improve immune system in normal and disease mode [18, 29] . A global analysis of metabonomic is untargeted discovery of AM-and PG-induced changes in the diversity of small molecules or endogenous substance in plasma samples. All detected compounds (known or unknown) in plasma samples were taken into investigation by LC-MS method. The typical total ion current (TIC) chromatograms of quality control (QC) samples containing AM and PG groups were shown in Figure 2 . The data (2176 variables) were used for multivariate statistical analysis. The normalized metabonomic data obtained from UPLC-Q-TOF MS/MS profile data (acquired in positive-ion and negative-ion modes) was processed by MPP software and imported into SIMCA-P software (Version 14.1, Umetrics AB, Sweden) for multivariate data analysis. Unsupervised PCA and supervised OPLS-DA models were made based on LC-MS-acquired data to clarify the metabolic changes and identify the metabolites of BC and treated groups.
In positive ion mode, there were 2160 variables in AM groups and 1714 variables in PG groups. In negative ion mode, there were 768 variables in AM groups and 717 variables in PG groups. All those variables were analyzed using PCA model with auto-scaling. AM (LAM, MAM, HAM) groups and BC group were separated into distinct clusters in PCA model in Figure 3A (positive) and 3C (negative), respectively. There were some partial overlaps among AM groups in negative ion mode. PG (LPG, MPG, HPG) groups and BC group were also separated into distinct clusters in PCA model in Figure 3E (positive) and 3G (negative), respectively. But there were overlaps to a large extent between MPG and HPG groups. It presented good similarity of various rats in the same group and good separation between BC and treated groups according to the information of PCA scores plot.
Metabolic profiling of plasma in treated mice was much different from those of the BC mice. To reduce the individual differences and make a further investigation into those metabolites, which were much close to the separation between the treated and BC groups. OPLS-DA models were built and applied to identify potential biomarkers on the base of the principal components PC1, PC2 and PC3. Score plot represented clear separation of treated and BC groups in Figure 3B , 3D, 3F and 3H. The validation plot Figure 3I , 3J, 3K and 3L with 200-iteration permutation test indicated that OPLS-DA models were valid and the permutated values were significantly lower than unpermutated original values. The potential biomarkers between treated and BC groups were screened by VIP values (>1) of OPLS-DA model, together with value of p < 0.05 and fold change ≥2.0. Endogenous metabolites were found in AM groups and in PG groups, compared to BC group. Furthermore, the identification of metabolite was confirmed by fragmentation of previously detected ions by target mass spectrometry. The detail information was showed in Table 2 . Figure 3 Plasmatic metabolic-profiling analysis of mice in the AM and PG groups during 30 days. A, C, E and G were principal component analysis (PCA) score plots; B, D, F and H were partial least-squares discriminant analysis (OPLS-DA) score plots; I, J, K and L were repeated permutation tests. 
Metabolic pathway analysis
With these identified metabolites, an integrated metabolic pathway analysis was conducted by MetaboAnalyst 3.6. It revealed that three metabolic pathways including glycerophospholipid metabolism, pyrimidine metabolism and sphingolipid metabolism were associated with AMinduced mice, seven metabolic pathways including phenylalanine, tyrosine and tryptophan biosynthesis, pentose and glucuronate interconversions, tyrosine metabolism, starch and sucrose metabolism, sphingolipid metabolism, glycerolipid metabolism and glycerophospholipid metabolism were associated with PM-induced mice in Table 3 and Figure 4 . Pyrimidine metabolism: Pyrimidine compounds are widely distributed in mammalian animals and provide materials for a variety of mammalian metabolism throughout life. The promotion of cell proliferation is the main function of pyrimidine metabolism [32] . Uracil is a base of RNA [33] and also appears during DNA replication [34] , playing an important role in protecting host from being attacked by pathogenic microorganisms [35] .
Sphingolipid metabolism: Sphingolipid metabolism was found to affect immune function by binding CD1 proteins [36] and used as chemoattractant for immune cells [37] . CD4+ T cell function was typically regulated by sphingolipid metabolites in several ways such as regulation of T cell activation, survival and proliferation [38] .
Phenylalanine, tyrosine and tryptophan biosynthesis & Tyrosine metabolism: When pathogenic microorganisms met their hosts, a series of self-protective strategy such as competition for nutrients was triggered. So, amino acid catabolism was used to prevent pathogen invasion and regulate immune responses [39] . Tyrosine is a precursor of protein tyrosine kinase [40] which could mediate immune system in a severe lymphoproliferative disorder mice model [41] .
Glycerolipid metabolism: LPA (16:0/0:0) is a kind of fatty acid which is stored as energy in complex organisms and animals. Glycerolipid metabolism plays a role in maintaining body temperature by modulating glycerolipid fatty acid cycle in vivo. As a regulation mechanism during animal signing processes, it contains numerous formation and hydrolysis of glycerolipid and releases heat with the consumption of ATP [42] .
Pentose and glucuronate interconversions & Starch and sucrose metabolism: Pentose and glucuronate provide numerous ribose 5-phosphate for nucleotide and nucleic acid synthetic reactions, playing an important role in cell metabolism [43] . UDP-glucose dehydrogenase is an essential process in pentose and glucuronate interconversions and UDP-glucose is converted to UDP-glucuronate [44] . When host was attacked, damaged cells will release UDP-glucose which trigger innate mucosal immune responses [45] .
Immune-related correlation analysis
Previous studies mainly focused on detection and identification of biomarker [46, 47] . Diversity of identified endogenous substances were regarded as being most closely to experimental model, regulating related signaling pathways. The relation between biomarkers and metabolic pathways was more like the many-to-many logic relationship. But it is hard to explain which endogenous substance response for specific change in the internal environment. In this correlation analysis section, these mentioned difficulties were smoothly solved.
Correlations between detected metabolites and four pharmacodynamic indexes was analyzed by a bivariate correlation test. The relation between them was presented by pearson's correlation coefficient. A two-tailed test of significance using SPSS 24.0 software at significance levels of p≤0.05 and 0.01. The higher value of pearson's correlation coefficient, the closer relationship between them. In this way, immune-related metabonomic analysis was deduced ( Figure 5 and Table 4 ). Glycerophospholipid metabolism was regulated in both AM and PG groups. Pyrimidine metabolism and sphingolipid metabolism were considered as the special pathway in AM groups. Energy metabolism and glycerolipid metabolism were the special pathway in PG groups.
In AM groups, the significant down regulation of uracil was found and it was negatively related closely to thymus index, indicating that uracil plays an important in cell proliferation in mice thymus. Uracil is a common naturally occurring pyrimidine found in RNA and also an essential key intermediate in adaptive immunity [48] . But, LysoPC(18:3(6Z,9Z,12Z)) and sphinganine may had an opposite effect on thymus, comparing to uracil. Meanwhile, LysoPC(18:3(6Z,9Z,12Z)) also had a positive effect on the proliferation of splenic lymphocytes and enhanced immunity by up regulation of LysoPC(18:3(6Z,9Z,12Z)). LysoPC(18:3(6Z,9Z,12Z)) is a lysophospholipid which have growth-related and -unrelated effects on lymphocytes and macrophages [49] . Besides, enhancement of spleen index was found in both LAM and MAM groups. In PG groups, much difference was found as compared to these in AM groups. 
Conclusion
AM and PG were widely used for improving the immunity human beings in Chinese long history clinical practice, accompanying higher dosage and longer time usage. Metabonomics has brought out a comprehensive strategy in detecting and identifying biomarkers based on LC-MS/MS method, assessing experimental model in molecular level (microscopic scale). On the other hand, immunological indexes assessed experimental model in cellular and organ level (macroscopic scale).
In this study, immune-related metabonomics based on UPLC-Q/TOF-MS technique, pharmacodynamic evaluation and correlation analysis were used to investigate biomarkers and metabolic changes in mice with long-term administration of AM and PG. Pharmacodynamic results showed that both AM and PG could promote the spleen index , splenic lymphocyte and cytotoxic activity of natural killer (NK) cells. But, there was no significant change in thymus index.
To reveal the immunological profile and discriminate the differences between the AM and PG at the molecular level, a further plasma metabonomic study was conducted. Metabolomic data suggested that glycerophospholipid metabolism is the common metabolic pathway of AM and PG. Sphingolipid metabolism (biomarker: sphinganine) and pyrimidine metabolism (biomarker: uracil) associated significantly with immunity in AM-mice. Besides, glycerolipid metabolism (biomarker: LPA(0:0/16:0)) and energy metabolism (biomarker: UDP-glucuronate) (pentose and glucuronate interconversions, starch and sucrose metabolism) were much close to PG-mice. LysoPC (18:3(6Z,9Z,12Z))) is a biomarker in AM groups.
Finally, a novel comprehensive metabonomic analysis method is applied to clarify the scientific connotation of similar clinical effect of traditional Chinese medicine in improving immunity, opening a window for new drug development.
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